Yaping Liu, MD, PhD - Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, United Kingdom Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
Michael A. Lawton, MPhil - Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, United Kingdom, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
Christine Lo, DPhil, MRCP - Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, United Kingdom, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom, Department of Neurology, Royal Hallamshire Hospital, Sheffield, United Kingdom
Francesca Bowring, M.Sc - Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, United Kingdom
Johannes C. Klein, MD, PhD - Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, United Kingdom, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom, Department of Neurology, John Radcliffe Hospital, Oxford, United Kingdom
Agustin Querejeta-Coma, MD - Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, United Kingdom, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom, Department of Neurology, John Radcliffe Hospital, Oxford, United Kingdom, Department of Neurology, Infanta Elena University Hospital, Valdemoro, Spain, Department of Neurology, Rey Juan Carlos University Hospital, Mostoles, Spain
Sangeeta Scotton, MBBS, MRCP - Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, United Kingdom
Jessica Welch, M.Sc - Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, United Kingdom
Jamil Razzaque, M.Sc - Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, United Kingdom
Thomas Barber, DPhil, MRCP - Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, United Kingdom, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom, Department of Neurology, John Radcliffe Hospital, Oxford, United Kingdom
Yoav Ben-Shlomo, PhD, MRCP - Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, United Kingdom, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
Michele T. Hu, PhD, FRCP - Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, United Kingdom, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom, Department of Neurology, John Radcliffe Hospital, Oxford, United Kingdom

Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.

Upon completion of this activity, learners will be able to:
1. Assess the impact of rapid eye movement sleep behavior disorder (RBD) on the change of motor and non-motor symptoms in early PD.
2. Understand the effect of rapid eye movement sleep behavior disorder (RBD) on the quality of life of patients with PD.
3. Evaluate the clinical implications and how early detection of rapid eye movement sleep behavior disorder (RBD) can benefit patients.

This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.

Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.

All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available below. All relevant financial relationships have been mitigated in advance of this program.

Sara Schaefer: Course Director
Nothing to Disclose

Veronica Santini: Reviewer
Consultant: Lunbeck, Northera
Grant: Biogen, Insightec, Inc., Genetech, Inc.

Michael A. Lawton: Author
Nothing to Disclose

Christine Lo: Author
Nothing to Disclose

Francesca Bowring: Author
Nothing to Disclose

Johannes C. Klein: Author
Nothing to Disclose

Agustin Querejeta-Coma: Author
Nothing to Disclose

Sangeeta Scotton: Author
Nothing to Disclose

Jessica Welch: Author
Nothing to Disclose

Jamil Razzaque: Author
Nothing to Disclose

Thomas Barber: Author
Nothing to Disclose

Yoav Ben-Shlomo: Author
Nothing to Disclose

Michele T. Hu: Author
Nothing to Disclose

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The International Parkinson and Movement Disorder Society designates this education activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.

MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

All individuals in control of content for this course are required to disclose all relevant financial relationships with commercial interests as defined by the ACCME.